カテゴリー： Market Monitor Global, 世界, 医療/バイオ

急性肝不全治療の世界市場見通し2023年-2029年

◆英語タイトル：Acute Liver Failure Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU4944）

◆商品コード：MMG23JU4944
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：62
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Acute Liver Failure Treatment Market 調査レポートは次の情報を含め、グローバルにおけるの急性肝不全治療市場規模と予測を収録しています。・世界の急性肝不全治療市場：売上、2018年-2023年、2024年-2029年
・世界の急性肝不全治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の急性肝不全治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「肝細胞移植」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

急性肝不全治療のグローバル主要企業は、Novartis AG、 Bayer AG、 Cardiorentis AG、 Cytokinetics, Inc.、 Orion Corporation、 Bristol-Myers Squibb Company、 PhaseBio Pharmaceuticals, InC、 Merck & Co、 CVie Therapeutics Limitedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、急性肝不全治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の急性肝不全治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の急性肝不全治療市場：タイプ別市場シェア、2022年
・肝細胞移植、肝移植補助、異種移植

世界の急性肝不全治療市場：用途別、2018年-2023年、2024年-2029年
世界の急性肝不全治療市場：用途別市場シェア、2022年
・病院、診療所、肝臓学術研究機関、法医学研究所

世界の急性肝不全治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の急性肝不全治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における急性肝不全治療のグローバル売上、2018年-2023年
・主要企業における急性肝不全治療のグローバル売上シェア、2022年
・主要企業における急性肝不全治療のグローバル販売量、2018年-2023年
・主要企業における急性肝不全治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis AG、 Bayer AG、 Cardiorentis AG、 Cytokinetics, Inc.、 Orion Corporation、 Bristol-Myers Squibb Company、 PhaseBio Pharmaceuticals, InC、 Merck & Co、 CVie Therapeutics Limited

*************************************************************

・調査・分析レポートの概要
急性肝不全治療市場の定義
市場セグメント
世界の急性肝不全治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の急性肝不全治療市場規模
世界の急性肝不全治療市場規模：2022年 VS 2029年
世界の急性肝不全治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの急性肝不全治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の急性肝不全治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：肝細胞移植、肝移植補助、異種移植
急性肝不全治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、肝臓学術研究機関、法医学研究所
急性肝不全治療の用途別グローバル売上・予測

・地域別市場分析
地域別急性肝不全治療市場規模 2022年と2029年
地域別急性肝不全治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis AG、 Bayer AG、 Cardiorentis AG、 Cytokinetics, Inc.、 Orion Corporation、 Bristol-Myers Squibb Company、 PhaseBio Pharmaceuticals, InC、 Merck & Co、 CVie Therapeutics Limited
...

Acute liver failure is a rare condition. It happens when your liver suddenly begins to lose its ability to function. This often happens right after an overdose of medicine or poisoning. For acute (sudden) liver failure, treatment includes: Intravenous (IV) fluids to maintain blood pressure; Medications such as laxatives or enemas to help flush toxins (poisons) out; Blood glucose (sugar) monitoring; glucose is given to the patient if blood sugar drops.
This report aims to provide a comprehensive presentation of the global market for Acute Liver Failure Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Liver Failure Treatment. This report contains market size and forecasts of Acute Liver Failure Treatment in global, including the following market information:
Global Acute Liver Failure Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Acute Liver Failure Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hepatocyte Transplantation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Liver Failure Treatment include Novartis AG, Bayer AG, Cardiorentis AG, Cytokinetics, Inc., Orion Corporation, Bristol-Myers Squibb Company, PhaseBio Pharmaceuticals, InC, Merck & Co and CVie Therapeutics Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Liver Failure Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Liver Failure Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Acute Liver Failure Treatment Market Segment Percentages, by Type, 2022 (%)
Hepatocyte Transplantation
Assisted Liver Transplantation
Xenotransplantation
Global Acute Liver Failure Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Acute Liver Failure Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Liver Academic and Research Institutes
Forensic Laboratories
Global Acute Liver Failure Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Acute Liver Failure Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Liver Failure Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acute Liver Failure Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Bayer AG
Cardiorentis AG
Cytokinetics, Inc.
Orion Corporation
Bristol-Myers Squibb Company
PhaseBio Pharmaceuticals, InC
Merck & Co
CVie Therapeutics Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Liver Failure Treatment, market overview.
Chapter 2: Global Acute Liver Failure Treatment market size in revenue.
Chapter 3: Detailed analysis of Acute Liver Failure Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Liver Failure Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Acute Liver Failure Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Liver Failure Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Liver Failure Treatment Overall Market Size
2.1 Global Acute Liver Failure Treatment Market Size: 2022 VS 2029
2.2 Global Acute Liver Failure Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Liver Failure Treatment Players in Global Market
3.2 Top Global Acute Liver Failure Treatment Companies Ranked by Revenue
3.3 Global Acute Liver Failure Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Liver Failure Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Liver Failure Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Liver Failure Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acute Liver Failure Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Liver Failure Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Acute Liver Failure Treatment Market Size Markets, 2022 & 2029
4.1.2 Hepatocyte Transplantation
4.1.3 Assisted Liver Transplantation
4.1.4 Xenotransplantation
4.2 By Type – Global Acute Liver Failure Treatment Revenue & Forecasts
4.2.1 By Type – Global Acute Liver Failure Treatment Revenue, 2018-2023
4.2.2 By Type – Global Acute Liver Failure Treatment Revenue, 2024-2029
4.2.3 By Type – Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Acute Liver Failure Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Liver Academic and Research Institutes
5.1.5 Forensic Laboratories
5.2 By Application – Global Acute Liver Failure Treatment Revenue & Forecasts
5.2.1 By Application – Global Acute Liver Failure Treatment Revenue, 2018-2023
5.2.2 By Application – Global Acute Liver Failure Treatment Revenue, 2024-2029
5.2.3 By Application – Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Acute Liver Failure Treatment Market Size, 2022 & 2029
6.2 By Region – Global Acute Liver Failure Treatment Revenue & Forecasts
6.2.1 By Region – Global Acute Liver Failure Treatment Revenue, 2018-2023
6.2.2 By Region – Global Acute Liver Failure Treatment Revenue, 2024-2029
6.2.3 By Region – Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Acute Liver Failure Treatment Revenue, 2018-2029
6.3.2 US Acute Liver Failure Treatment Market Size, 2018-2029
6.3.3 Canada Acute Liver Failure Treatment Market Size, 2018-2029
6.3.4 Mexico Acute Liver Failure Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Acute Liver Failure Treatment Revenue, 2018-2029
6.4.2 Germany Acute Liver Failure Treatment Market Size, 2018-2029
6.4.3 France Acute Liver Failure Treatment Market Size, 2018-2029
6.4.4 U.K. Acute Liver Failure Treatment Market Size, 2018-2029
6.4.5 Italy Acute Liver Failure Treatment Market Size, 2018-2029
6.4.6 Russia Acute Liver Failure Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Acute Liver Failure Treatment Market Size, 2018-2029
6.4.8 Benelux Acute Liver Failure Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Acute Liver Failure Treatment Revenue, 2018-2029
6.5.2 China Acute Liver Failure Treatment Market Size, 2018-2029
6.5.3 Japan Acute Liver Failure Treatment Market Size, 2018-2029
6.5.4 South Korea Acute Liver Failure Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Acute Liver Failure Treatment Market Size, 2018-2029
6.5.6 India Acute Liver Failure Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Acute Liver Failure Treatment Revenue, 2018-2029
6.6.2 Brazil Acute Liver Failure Treatment Market Size, 2018-2029
6.6.3 Argentina Acute Liver Failure Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Acute Liver Failure Treatment Revenue, 2018-2029
6.7.2 Turkey Acute Liver Failure Treatment Market Size, 2018-2029
6.7.3 Israel Acute Liver Failure Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Acute Liver Failure Treatment Market Size, 2018-2029
6.7.5 UAE Acute Liver Failure Treatment Market Size, 2018-2029
7 Acute Liver Failure Treatment Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Acute Liver Failure Treatment Major Product Offerings
7.1.4 Novartis AG Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Acute Liver Failure Treatment Major Product Offerings
7.2.4 Bayer AG Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News & Latest Developments
7.3 Cardiorentis AG
7.3.1 Cardiorentis AG Company Summary
7.3.2 Cardiorentis AG Business Overview
7.3.3 Cardiorentis AG Acute Liver Failure Treatment Major Product Offerings
7.3.4 Cardiorentis AG Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.3.5 Cardiorentis AG Key News & Latest Developments
7.4 Cytokinetics, Inc.
7.4.1 Cytokinetics, Inc. Company Summary
7.4.2 Cytokinetics, Inc. Business Overview
7.4.3 Cytokinetics, Inc. Acute Liver Failure Treatment Major Product Offerings
7.4.4 Cytokinetics, Inc. Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.4.5 Cytokinetics, Inc. Key News & Latest Developments
7.5 Orion Corporation
7.5.1 Orion Corporation Company Summary
7.5.2 Orion Corporation Business Overview
7.5.3 Orion Corporation Acute Liver Failure Treatment Major Product Offerings
7.5.4 Orion Corporation Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.5.5 Orion Corporation Key News & Latest Developments
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Company Summary
7.6.2 Bristol-Myers Squibb Company Business Overview
7.6.3 Bristol-Myers Squibb Company Acute Liver Failure Treatment Major Product Offerings
7.6.4 Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.7 PhaseBio Pharmaceuticals, InC
7.7.1 PhaseBio Pharmaceuticals, InC Company Summary
7.7.2 PhaseBio Pharmaceuticals, InC Business Overview
7.7.3 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Major Product Offerings
7.7.4 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.7.5 PhaseBio Pharmaceuticals, InC Key News & Latest Developments
7.8 Merck & Co
7.8.1 Merck & Co Company Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Acute Liver Failure Treatment Major Product Offerings
7.8.4 Merck & Co Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.8.5 Merck & Co Key News & Latest Developments
7.9 CVie Therapeutics Limited
7.9.1 CVie Therapeutics Limited Company Summary
7.9.2 CVie Therapeutics Limited Business Overview
7.9.3 CVie Therapeutics Limited Acute Liver Failure Treatment Major Product Offerings
7.9.4 CVie Therapeutics Limited Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.9.5 CVie Therapeutics Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Acute Liver Failure Treatment Market Opportunities & Trends in Global Market
Table 2. Acute Liver Failure Treatment Market Drivers in Global Market
Table 3. Acute Liver Failure Treatment Market Restraints in Global Market
Table 4. Key Players of Acute Liver Failure Treatment in Global Market
Table 5. Top Acute Liver Failure Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Liver Failure Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Liver Failure Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Liver Failure Treatment Product Type
Table 9. List of Global Tier 1 Acute Liver Failure Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Liver Failure Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Liver Failure Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Acute Liver Failure Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Liver Failure Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Liver Failure Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Liver Failure Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Liver Failure Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Liver Failure Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Liver Failure Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Novartis AG Company Summary
Table 31. Novartis AG Acute Liver Failure Treatment Product Offerings
Table 32. Novartis AG Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Bayer AG Company Summary
Table 35. Bayer AG Acute Liver Failure Treatment Product Offerings
Table 36. Bayer AG Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer AG Key News & Latest Developments
Table 38. Cardiorentis AG Company Summary
Table 39. Cardiorentis AG Acute Liver Failure Treatment Product Offerings
Table 40. Cardiorentis AG Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Cardiorentis AG Key News & Latest Developments
Table 42. Cytokinetics, Inc. Company Summary
Table 43. Cytokinetics, Inc. Acute Liver Failure Treatment Product Offerings
Table 44. Cytokinetics, Inc. Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Cytokinetics, Inc. Key News & Latest Developments
Table 46. Orion Corporation Company Summary
Table 47. Orion Corporation Acute Liver Failure Treatment Product Offerings
Table 48. Orion Corporation Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Orion Corporation Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Company Summary
Table 51. Bristol-Myers Squibb Company Acute Liver Failure Treatment Product Offerings
Table 52. Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Company Key News & Latest Developments
Table 54. PhaseBio Pharmaceuticals, InC Company Summary
Table 55. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Product Offerings
Table 56. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. PhaseBio Pharmaceuticals, InC Key News & Latest Developments
Table 58. Merck & Co Company Summary
Table 59. Merck & Co Acute Liver Failure Treatment Product Offerings
Table 60. Merck & Co Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. Merck & Co Key News & Latest Developments
Table 62. CVie Therapeutics Limited Company Summary
Table 63. CVie Therapeutics Limited Acute Liver Failure Treatment Product Offerings
Table 64. CVie Therapeutics Limited Acute Liver Failure Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. CVie Therapeutics Limited Key News & Latest Developments
List of Figures
Figure 1. Acute Liver Failure Treatment Segment by Type in 2022
Figure 2. Acute Liver Failure Treatment Segment by Application in 2022
Figure 3. Global Acute Liver Failure Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Liver Failure Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acute Liver Failure Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Liver Failure Treatment Revenue in 2022
Figure 8. By Type - Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Acute Liver Failure Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 16. US Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 28. China Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Acute Liver Failure Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Acute Liver Failure Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis AG Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer AG Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cardiorentis AG Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cytokinetics, Inc. Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Orion Corporation Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck & Co Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CVie Therapeutics Limited Acute Liver Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 急性肝不全治療の世界市場見通し2023年-2029年(Acute Liver Failure Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

急性肝不全治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp